{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Clinical trials",
      "SARS-CoV-2",
      "coronavirus",
      "pathogenesis",
      "synthetic and semi-synthetic antiviral drugs."
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33280595",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2174/1389557520666201204162103"
    ],
    "Journal": {
      "ISSN": "1875-5607",
      "JournalIssue": {
        "Volume": "21",
        "Issue": "8",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Mini reviews in medicinal chemistry",
      "ISOAbbreviation": "Mini Rev Med Chem"
    },
    "ArticleTitle": "Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19.",
    "Pagination": {
      "StartPage": "1004",
      "EndPage": "1016",
      "MedlinePgn": "1004-1016"
    },
    "Abstract": {
      "AbstractText": [
        "The novel coronavirus disease-19 (COVID-19) is a global pandemic that emerged from Wuhan, China, and has spread all around the world, affecting 216 countries or territories with 21,732,472 people infected and 770,866 deaths globally (as per WHO COVID-19 updates of August 18, 2020). Continuous efforts are being made to repurpose the existing drugs and develop vaccines for combating this infection. Despite, to date, no certified antiviral treatment or vaccine exists. Although, few candidates have displayed their efficacy in in vitro studies and are being repurposed for COVID- 19 treatment. This article summarizes synthetic and semi-synthetic compounds displaying potent activity in clinical uses or studies on COVID-19 and also focuses on the mode of action of drugs being repositioned against COVID-19."
      ],
      "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur 495 009, C.G., India."
          }
        ],
        "LastName": "Shirbhate",
        "ForeName": "Ekta",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur 495 009, C.G., India."
          }
        ],
        "LastName": "Patel",
        "ForeName": "Preeti",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur 495 009, C.G., India."
          }
        ],
        "LastName": "Patel",
        "ForeName": "Vijay K",
        "Initials": "VK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Kedah Darul Aman, Malaysia."
          }
        ],
        "LastName": "Veerasamy",
        "ForeName": "Ravichandran",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra 136 119, Haryana, India."
          }
        ],
        "LastName": "Sharma",
        "ForeName": "Prabodh C",
        "Initials": "PC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacy, Birla Institute of Technology, Mesra - Ranchi-835 215, Jharkhand, India."
          }
        ],
        "LastName": "Sinha",
        "ForeName": "Barij N",
        "Initials": "BN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur 495 009, C.G., India."
          }
        ],
        "LastName": "Rajak",
        "ForeName": "Harish",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Mini Rev Med Chem",
    "NlmUniqueID": "101094212",
    "ISSNLinking": "1389-5575"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}